[EFFECT] Galmed Pharmaceuticals Ltd. SEC Filing

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

EFFECT

04/02/2026 - 12:15 AM

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	April 1, 2026

Accession Number:

0001493152-26-014239

Submission Type:

POS AM

Source: View Original Filing on SEC EDGAR